Innovations and New Treatment Strategies in Heart Failure



Similar documents
Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

CARDIOLOGY UPDATE 2004

Contemporary Management of Cardiovascular Disease

Heart Failure: From Prevention to Intervention

7th annual ConFerenCe location

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, Participating Faculty

2014 Emerging Faculty Participants

CARDIOLOGY UPDATE 2015 A Patient Management Approach

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

Contemporary Multidisciplinary Cardiovascular Conference

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Advanced Heart Failure & Transplantation Fellowship Program

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Heart Failure Management for Nurse Practitioners, Physician Assistants, and Primary Care Providers

CARDIAC NURSING. Graduate Diploma in Nursing Science. Overview. Entry Requirements. Fees. Contact. Teaching Methods.

Heart Failure Review Course

Jeffrey M. Carlton Heart & Vascular Institute Presents

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

All Patient Refined DRGs (APR-DRGs) An Overview. Presented by Treo Solutions

The 5th Annual Chicago Cardiovascular Update Meeting

Madeline M. Mimi O Donnell, DNP, RN (W) (617) modonnell@mghihp.edu

Contemporary Management of Cardiovascular Disease

21st Annual OSF Cardiovascular Symposium

Rx Updates New Guidelines, New Medications What You Need to Know

Antiplatelet and Antithrombotics From clinical trials to guidelines

LEADING-EDGE Cardiovascular Care

Cardiology ARCP Decision Aid August 2014

Survey of Current Issues in Surgical Anesthesia

Minimally Invasive Cardiac Surgery

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

CARDIOLOGY ROTATION GOALS AND OBJECTIVES

Cardiac Care Associates 2014 Annual Meeting

Surgeons Role in Atrial Fibrillation

CURRICULUM VITÆ. Prof. FRANCESCO DONATELLI

Diagnostic and Therapeutic Procedures

I. Current Cardiac Rehabilitation Requirements

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Intelligent Monitoring Report. Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

National Coverage Determination (NCD) for Cardiac Rehabilitation Programs for Chronic Heart Failure ( )

Renovascular Disease. Renal Artery and Arteriosclerosis

Educational Goals & Objectives

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

The new Heart Failure pathway

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

The Heart and Vascular Institute at Englewood Hospital and Medical Center

Perioperative Cardiac Evaluation

Stanford s Cardiovascular Surgery and Medicine Symposium

SECOND CARDIOLOGY JOINT SEMINAR. Rome, April 12-13, Cardiovascular Center OLV Clinic Aalst Belgium. and

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

Prognostic impact of uric acid in patients with stable coronary artery disease

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

New Oral Anticoagulants. How safe are they outside the trials?

Ch. 138 CARDIAC CATHETERIZATION SERVICES CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

SUCCESS WITH FAILURE: An Advanced Heart Disease Symposium

INFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation

3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin.

Atrial Fibrillation The High Risk Obese Patient

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Atrial Fibrillation Management Across the Spectrum of Illness

Treatments to Restore Normal Rhythm

HEART CENTER. Touching Lives

Updates to the Alberta Drug Benefit List. Effective January 1, 2016

Living with. Atrial Fibrillation

Atrial fibrillation. Quick reference guide. Issue date: June The management of atrial fibrillation

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

Cardiac Rehabilitation

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

Anticoagulation at the end of life. Rhona Maclean

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

What to Know About. Atrial Fibrillation

CARDIOLOGY 10 YEARS PAST 10 YEARS FUTURE

Florida Alcohol and Drug Abuse Association. Presented to the Behavioral Health Quarterly Meeting Pensacola, Florida April 23, 2014

CARDIAC CARE. Giving you every advantage

The Copernican Revolution in Ischemic Heart Diseases: the day after

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Using EHRs for Heart Failure Therapy Recommendation Using Multidimensional Patient Similarity Analytics

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen

FRIDAY, FEBRUARY 26, :15 A.M. TO 3:15 P.M.

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services

Transcription:

Innovations and New Treatment Strategies in Heart Failure 8th International Symposium, September 18th- 19th, 2015 Portorož, Slovenia Friday September 18th Morning Sessions 9.00-9.15 Opening Session 1 Heart Failure: Beyond Conventional Room 1 9.15-10.45 Panel B. Vrtovec, R. Radovančević, I. Gregorič 9.15-9.30 Right ventricular failure and pulmonary hypertension F. Haddad Stanford USA 9.30-9.45 Amyloid heart disease L. Potena Bologna IT 9.45-10.00 Heart failure in pregnant women with heart disease M. Koželj Ljubljana SI 10.00-10.15 Diabetic cardiomyopathy A. Janež Ljubljana SI 10.15-10.30 Cardiorenal syndrome D. Taylor Cleveland USA 10.30-10.45 Discussion 10.45-11.15 Coffee Break Session 2 Interventions in Heart Failure: When to Intervene? Room 1 11.15-12.45 Panel A. Zuckermann, F. Wagner, M. Koželj 11.15-11.30 Which patients benefit from CRT? I. Zupan Ljubljana SI 11.30-11.45 When to refer a heart failure patient for an EP study and catheter ablation? A. Pernat Ljubljana SI 11.45-12.00 Which heart failure patients should be revascularized? J. Kšela Ljubljana SI 12.00-12.15 Which heart failure patients should be referred for valve surgery? A. Wasler Graz AUT 12.15-12.30 Which heart failure patients should undergo percutaneous mitral valve repair? M. Bunc Ljubljana SI 12.30-12.45 Discussion Session 3 Symposium Amgen Room 1 12.45-13.00 12.45-13.00 PCSK9 inhibitors - from lowering LDL cholesterol to reducing cardiovascular events A. Blinc Ljubljana SI 13.00-14.00 Lunch Break

Friday September 18th Afternoon Sessions Session 4 How to Treat Advanced Heart Failure Room 1 14.00-15.30 Panel S. Hunt, J. Kobashigawa, J. Kšela 14.00-14.15 Who benefits from left ventricular restoration? P. Przybylowski Krakow POL 14.15-14.30 When to consider short- term mechanical circulatory support? I. Gregorič Houston USA 14.30-14.45 When to consider long- term mechanical circulatory support? A. Zuckermann Vienna AUT 14.45-15.00 Anticoagulation during mechanical circulatory support P. Van der Starre Stanford USA 15.00-15.15 Total artificial heart: a long- term solution? I. Kneževič Ljubljana SI 15.15-15.30 Discussion 15.30-16.00 Coffee Break Session 5 Future Perspectives of Heart Failure Management Room 1 16.00-17.30 Panel F. Haddad, D. Taylor, L. Potena 16.00-16.15 Medical management B. Vrtovec Ljubljana SI 16.15-16.30 Heart failure coronary interventions B. Guzik Krakow POL 16.30-16.45 Stem cell therapy J. Kastrup Copenhagen DK 16.45-17.00 Nano therapeutics in heart failure G. Torre- Amione Houston USA 17.00-17.15 Heart transplantation and organ preservation J. Kobashigawa Los Angeles USA 17.15-17.30 Discussion Session 6 Keynote Lecture Room 1 17.30-18.00 17.30-18.00 Cardiac transplantation - still a relevant therapy in 2015? S. Hunt Stanford USA 18.00-18.15 Break Session 7 Symposium Boehringer Room 1 18.15-18.45 18.15-18.30 Innovations in anticoagulation therapy: the new era has arrived A. Pernat Ljubljana SI 18.30-18.45 Innovations in anticoagulation therapy: a combination of non- valvular atrial fibrillation and M. Gričar Ljubljana SI coronary stent

Saturday September 19th Morning Sessions Session 8 Symposium Lek Room 1 9.00-9.45 9.00-9.20 The role of iron deficiency and anemia in heart failure T. Ravnikar Izola SI 9.20-9.45 Treatment options for iron deficiency in heart failure M. Šebeštjen Ljubljana SI 9.45-10.00 Break Session 9 Workshop: Heart Failure Outpatient Management Room 1 10.00-12.00 Panel M. Petek- Šter, R. Okrajšek, M. Gričar 10.00-10.15 Diagnostics and differential diagnosis in chronic heart failure outpatients M. Šebeštjen Ljubljana SI 10.15-10.30 Therapeutic algorithms for outpatient management of chronic heart failure B. Jug Ljubljana SI 10.30-10.45 Heart failure and hypertension J. Brguljan Ljubljana SI 10.45-11.00 Management of acute heart failure: perspectives of a general practitioner M. Petek- Šter Trebnje SI 11.00-11.15 Common mistakes in heart failure management M. Gričar Ljubljana SI 11.15-11.30 Case report with panel discussion M. Nemanič Kostelec Črnomelj SI 11.30-11.45 Case report with panel discussion S. Jenkole Trebnje SI 11.45-12.00 Case report with panel discussion Z. Kralj Ljubljana SI Session 10 Workshop: Heart Failure Nursing Room 2 10.00-12.00 I. Trampuš, S. Ocepek 10.00-10.15 Heart failure outpatient titration of ACE inhibitors and sartans K. Janša Trontelj Ljubljana SI 10.15-10.30 Beta blocker titration in heart failure patients R. Lošič Maribor SI 10.30-10.45 The role of nursing in heart failure awareness M. Kladnik Slovenj Gradec SI 10.45-11.00 Heart failure nursing in cardiogenic shock patient S. Ocepek Ljubljana SI 11.00-11.15 Preliminary results of U4H- telemedicine project Slovenj Gradec M. Rakuša Slovenj Gradec SI 11.15-11.30 Novel concepts in mechanical circulatory support V. Andročec Ljubljana SI 11.30-11.45 The results of healthcare professional survey R. Evačić Zagreb CRO 11.45-12.00 The effects of sleep deprivation on job performance N. Strojan Ljubljana SI 12.00-13.00 Lunch Break

Saturday September 19th Afternoon Sessions Session 11 Workshop: Challenges in Heart Transplantation Room 2 13.00-14.30 Panel S. Hunt, J. Kobashigawa, D. Taylor, A. Zuckermann, I. Gregoric, F. Haddad, I. Knezevič, L. Potena, F. Wagner, G. Torre, B. Vrtovec 13.00-13.10 Preservation and storage techniques in heart transplantation M. Jelenc Ljubljana SI 13.10-13.20 Non- compaction cardiomyopathy: LVAD or transplant? A. Cerar Ljubljana SI 13.20-13.30 Amyloid cardiomyopathy and heart transplantation G. Zemljič Ljubljana SI 13.20-13.40 Takotsubo cardiomyopathy in donor hearts T. Pintar Ljubljana SI 13.40-13.50 Levosimendan in heart transplant surgery S. Mušič Ljubljana SI 13.50-14.00 Renal sparing strategies after heart transplantation G. Poglajen Ljubljana SI 14.00-14.10 Compliance in heart transplant recipient - the role of once- daily tacrolimus therapy M. Čikeš Zagreb CRO 14.10-14.20 Testosterone and heart: myth or reality? M. Jensterle Ljubljana SI 14.20-14.30 Imaging and coronary interventions in heart transplant recipients W. Wojakowski Katowice POL 14.30 Meeting Adjournment and Farewell Reception